FIELD: chemistry.
SUBSTANCE: invention relates to the chemistry of biologically active compounds, specifically to new substituted O-(phenylacryloyl)oximes 3,4,6,7,8,9-hexahydrodibenzo[b,d]furan-1-(2H)-one of the general formula (1) with anticonvulsant activity. In formula (1), one or more of the substituents R1-R4 can be halogen atoms, alkyl groups, alkoxy groups, trifluoromethyl groups, while the remaining substituents are hydrogen; or two of the substituents R1-R4 are simultaneously -O-CH2-O-group, while the remaining substituents are hydrogens.
EFFECT: obtaining cinnamoyl derivatives of dibenzofuranone oxime with anticonvulsant activity.
7 cl, 6 dwg, 4 tbl, 15 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AMINOALKYL DERIVATIVES OF DIBENZOFURANONE OXIME EXHIBITING ANTICONVULSANT ACTIVITY | 2020 |
|
RU2773021C2 |
| DIBENZOFURAN OXIME DERIVANTS WITH ANTICONVULSANT AND NEUROPROTECTIVE ACTIVITY | 2018 |
|
RU2744758C2 |
| DERIVATIVES OF 1,2,3,4-TETRAHYDROPYRIDO[4,3-b]INDOLE-CONTAINING PHENOTHIAZINES AS INHIBITORS OF CHOLINESTERASES AND BLOCKERS OF SEROTONIN RECEPTORS 5-HT, METHODS OF OBTAINING THEIR CHLOROHYDRATES AND BASED ON THEM PHARMACEUTICAL PREPARATION | 2013 |
|
RU2530881C1 |
| DRUG FOR IMPROVING BLOOD SUPPLY OF ISCHEMIZED BRAIN | 2019 |
|
RU2747202C2 |
| SELECTIVE INHIBITORS OF CYCLOXYGENASE AND METHOD FOR THEIR PRODUCTION | 2016 |
|
RU2631317C1 |
| DERIVATIVE OF BISAMIDES OF DICARBOXYLIC ACIDS, ITS USE, PHARMACEUTICAL COMPOSITION BASED ON IT, METHODS FOR ITS PRODUCTION | 2018 |
|
RU2719464C2 |
| BISAMIDE DERIVATIVE OF DICARBOXYLIC ACIDS, ITS USE, PHARMACEUTICAL COMPOSITION BASED ON IT, METHODS FOR ITS OBTAINING | 2020 |
|
RU2815401C2 |
| 4-OXO-N-(FURAN-2-YLMETHYL)-4-(4-CHLOROPHENYL)-2-((3-CYANO-4,5,6,7-TETRAHYDROBENZO[B]THIOPHEN-2-YL)AMINO)BUT-2-ENAMIDE WITH ANALGESIC ACTIVITY | 2022 |
|
RU2798425C1 |
| BISAMIDES DERIVATIVE OF DICARBOXYLIC ACIDS, USE THEREOF, PHARMACEUTICAL COMPOSITION BASED THEREON, METHODS FOR PRODUCTION THEREOF | 2018 |
|
RU2725881C2 |
| BICAMIDES DERIVATIVE OF DICARBOXYLIC ACIDS, USE THEREOF, A PHARMACEUTICAL COMPOSITION BASED THEREON, METHODS FOR PRODUCTION THEREOF | 2018 |
|
RU2721421C2 |
